Timeline
M Ventures
Merck KGaA's corporate venture arm; joined T-Therapeutics' $133m Series B in November 2026.
1 of 1 entries (1 events, 0 interactions)
Filters
#17 5 Nov
Merck KGaA's corporate venture arm; joined T-Therapeutics' $133m Series B in November 2026.
1 of 1 entries (1 events, 0 interactions)